Published in Iran J Child Neurol on January 01, 2014
Novel homozygous PANK2 mutation identified in a consanguineous Chinese pedigree with pantothenate kinase-associated neurodegeneration. Biomed Rep (2016) 0.75
Anesthetic approach to patient with Down syndrome and Hallervorden-Spatz disease who underwent tooth extraction. J Res Med Sci (2015) 0.75
FTL mutation in a Chinese pedigree with neuroferritinopathy. Neurol Genet (2016) 0.75
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet (2001) 5.34
Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet (2012) 3.80
Racial hygiene, active euthanasia, and Julius Hallervorden. Neurology (1992) 3.23
Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet (2008) 3.08
Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology (2008) 2.57
T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology (2008) 2.38
Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol (2006) 1.86
Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology (2006) 1.72
Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am J Hum Genet (2008) 1.71
Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet (2011) 1.70
Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging (2010) 1.56
Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology. Am J Pathol (2000) 1.52
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain (2006) 1.48
Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Hum Mutat (2010) 1.44
Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2. J Neurosci (2005) 1.44
Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurol Scand (1994) 1.29
Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation. Am J Hum Genet (2013) 1.09
PANK2 and C19orf12 mutations are common causes of neurodegeneration with brain iron accumulation. Mov Disord (2012) 1.08
Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome. Am J Hum Genet (2008) 1.05
Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology. Acta Neuropathol (2000) 1.04
Neurodegeneration with brain iron accumulation: a diagnostic algorithm. Semin Pediatr Neurol (2012) 1.04
The neurological presentation of ceruloplasmin gene mutations. Eur Neurol (2008) 1.02
Neurodegeneration with brain iron accumulation: from genes to pathogenesis. Semin Pediatr Neurol (2006) 0.96
Pantothenate kinase-associated neurodegeneration is not a synucleinopathy. Neuropathol Appl Neurobiol (2013) 0.95
Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation. Neurobiol Dis (2010) 0.92
The Clinical Features and Diagnosis of Canavan's Disease: A Case Series of Iranian Patients. Iran J Child Neurol (2014) 0.77
Pregabalin in childhood epilepsy: a clinical trial study. Iran J Child Neurol (2014) 0.75